Furthermore, correcting abnormal gene expression in tumor cells is a trend in targeted therapy for tumors, and the successful application of liposomes for mRNA and siRNA delivery has made nanomaterial-based gene editing for regulating TSHR possible in thyroid cancer therapy (126). Here, TSHR is linked to neoplasm.